Insider Transactions in Q3 2025 at Relay Therapeutics, Inc. (RLAY)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 29
2025
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
18,276
-4.69%
|
$54,828
$3.68 P/Share
|
|
Jul 29
2025
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
26,701
-4.61%
|
$80,103
$3.68 P/Share
|
|
Jul 29
2025
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
18,380
-5.2%
|
$55,140
$3.68 P/Share
|
|
Jul 29
2025
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
15,724
-3.99%
|
$47,172
$3.68 P/Share
|
|
Jul 28
2025
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,637
-0.42%
|
$4,911
$3.74 P/Share
|
|
Jul 28
2025
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
4,069
-0.7%
|
$12,207
$3.74 P/Share
|
|
Jul 28
2025
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,701
-0.48%
|
$5,103
$3.74 P/Share
|
|
Jul 28
2025
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
1,359
-0.34%
|
$4,077
$3.74 P/Share
|
|
Jul 09
2025
|
Sanjiv Patel President and CEO |
SELL
Open market or private sale
|
Direct |
61,379
-3.77%
|
$184,137
$3.57 P/Share
|